Regulation of angiotensin II receptors beyond the classical pathway

Clinical Science

Volumn 123, Issue 4, 2012, Pages 193-203

  Horiuchi, Masatsugu ^a   Iwanami, Jun ^a   Mogi, Masaki ^a  

^a EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiotensin II receptor; Angiotensin II type 1 receptor blocker; Angiotensin receptor interacting protein; Cardiovascular disease; Peroxisome proliferator activated receptor; Renin angiotensin system

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR ANTAGONIST; ANGIOTENSIN[1-7]; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IRBESARTAN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TELMISARTAN; AGTRAP PROTEIN, HUMAN; ANGIOTENSIN RECEPTOR; ARAP1 PROTEIN, HUMAN; CARRIER PROTEIN; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; MTUS1 PROTEIN, HUMAN; PROTEIN TYROSINE PHOSPHATASE SHP 1; PTPN6 PROTEIN, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; CARBOXY TERMINAL SEQUENCE; CARDIOVASCULAR DISEASE; CELL PROLIFERATION; CEREBROVASCULAR DISEASE; COGNITIVE DEFECT; COMPLEX FORMATION; DIMERIZATION; DRUG MECHANISM; HUMAN; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; ANIMAL; DRUG POTENTIATION; METABOLISM; PHYSIOLOGY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANIMALS; CARRIER PROTEINS; GTPASE-ACTIVATING PROTEINS; HUMANS; PEPTIDYL-DIPEPTIDASE A; PPAR GAMMA; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 6; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTORS, ANGIOTENSIN; RENIN-ANGIOTENSIN SYSTEM; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS;

EID: 84862322861     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20110677     Document Type: Review

References (81)

1. de Gasparo, M., Catt, K. J., Inagami, T., Wright, J. W. and Unger, T. (2000) International Union of Pharmacology. XXIII. The angiotensin II receptors. Pharmacol. Rev. 52, 415-472
2. Horiuchi, M. and Mogi, M. (2011) Role of angiotensin II receptor subtype activation in cognitive function and ischaemic brain damage. Br. J. Pharmacol. 163, 1122-1130
3. 2 receptor agonist. J. Med. Chem. 47, 5995-6008
4. 2 receptor research and therapeutic potential. J. Renin Angiotensin Aldosterone Syst. 11, 75-77
5. Ferrario, C. M. (2011) ACE2: more of Ang-(1-7) or less AngII? Curr. Opin. Nephrol. Hypertens. 20, 1-6
6. Santos, R. A., Ferreira, A. J., Simões, E. and Silva, A. C. (2008) Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis. Exp. Physiol. 93, 519-527
7. 1 receptor axis vs. ACE2-angiotensin-(1-7)-Mas receptor axis. Hypertens. Res. 32, 533-536
8. 2 receptors. Clin. Sci. 121, 297-303
9. Mogi, M., Iwai, M. and Horiuchi, M. (2007) Emerging concepts of regulation of angiotensin II receptors: new players and targets for traditional receptors. Arterioscler. Thromb. Vasc. Biol. 27, 2532-2539
10. 1 receptor improves adipocyte differentiation in atherosclerotic and diabetic models. Am. J. Hypertens. 21, 206-212
11. 2 receptor deficiency attenuates adipocyte differentiation and decreases adipocyte number in atherosclerotic mice. Am. J. Hypertens. 22, 784-791
12. Benson, S. C., Pershadsingh, H. A., Ho, C. I., Chittiboyina, A., Desai, P., Pravenec, M., Qi, N., Wang, J., Avery, M. A. and Kurtz, T.W. (2004) Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARγ -modulating activity. Hypertension 43, 993-1002
13. Schupp, M., Janke, J., Clasen, R., Unger, T. and Kintscher, U. (2004) Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-γ activity. Circulation 109, 2054-2057
14. Savoia, C., Burger, D., Nishigaki, N., Montezano, A. and Touyz, R. M. (2011) Angiotensin II and the vascular phenotype in hypertension. Expert Rev. Mol. Med. 13, e11
15. Daviet, L., Lehtonen, J. Y., Tamura, K., Griese, D. P., Horiuchi, M. and Dzau, V. J. (1999) Cloning and characterization of ATRAP, a novel protein that interacts with the angiotensin II type 1 receptor. J. Biol. Chem. 274, 17058-17062
16. Oshita, A., Iwai, M., Chen, R., Ide, A., Okumura, M., Fukunaga, S., Yoshii, T., Mogi, M., Higaki, J. and Horiuchi, M. (2006) Attenuation of inflammatory vascular remodeling by angiotensin II type 1 receptor-associated protein. Hypertension. 48, 671-676
17. 1 receptor in the mouse renal tubules. Kidney Int. 69, 488-494
18. 1 receptor and inhibits vascular smooth muscle cell growth. Biochem. Biophys. Res. Commun. 279, 938-941
19. Azuma, K., Tamura, K., Shigenaga, A., Wakui, H., Masuda, S., Tsurumi-Ikeya, Y., Tanaka, Y., Sakai, M., Matsuda, M., Hashimoto, T. et al. (2007) Novel regulatory effect of angiotensin II type 1 receptor-interacting molecule on vascular smooth muscle cells. Hypertension. 50, 926-932
20. Guo, S., Lopez-Ilasaca, M. and Dzau, V. J. (2005) Identification of calcium-modulating cyclophilin ligand (CAML) as transducer of angiotensin II-mediated nuclear factor of activated T cells (NFAT) activation. J. Biol. Chem. 280, 12536-12541
21. Min, L. J., Mogi, M., Tamura, K., Iwanami, J., Sakata, A., Fujita, T., Tsukuda, K., Jing, F., Iwai, M. and Horiuchi, M. (2009) Angiotensin II type 1 receptor-associated protein prevents vascular smooth muscle cell senescence via inactivation of calcineurin/nuclear factor of activated T cells pathway. J. Mol. Cell Cardiol. 47, 798-809
22. Oppermann, M., Gess, B., Schweda, F. and Castrop, H. (2010) ATRAP deficiency increases arterial blood pressure and plasma volume. J. Am. Soc. Nephrol. 21, 468-477
23. Masuda, S., Tamura, K., Wakui, H., Maeda, A., Dejima, T., Hirose, T., Toyoda, M., Azuma, K., Ohsawa, M., Kanaoka, T. et al. (2010) Expression of angiotensin II type 1 receptor-interacting molecule in normal human kidney and IgA nephropathy. Am. J. Physiol. Renal Physiol. 299, F720-F731
24. Guo, D. F., Chenier, I., Tardif, V., Orlov, S. N. and Inagami, T. (2003) Type 1 angiotensin II receptor-associated protein ARAP1 binds and recycles the receptor to the plasma membrane. Biochem. Biophys. Res. Commun. 310, 1254-1265
25. Guo, D. F., Chenier, I., Lavoie, J. L., Chan, J. S., Hamet, P., Tremblay, J., Chen, X. M., Wang, D. H. and Inagami, T. (2006) Development of hypertension and kidney hypertrophy in transgenic mice overexpressing ARAP1 gene in the kidney. Hypertension 48, 453-459
26. Cook, J. L., Re, R. N., deHaro, D. L., Abadie, J. M., Peters, M. and Alam, J. (2008) The trafficking protein GABARAP binds to and enhances plasma membrane expression and function of the angiotensin II type 1 receptor. Circ. Res. 102, 1539-1547
27. 2 receptor-interacting proteins. Trends Endocrinol. Metab. 21, 684-690
28. 2 receptor - implications for cardiac pathophysiology. J. Renin Angiotensin Aldosterone Syst. 11, 7-17
29. 2 receptor agonists: arylbenzylimidazole structure-activity relationships. J. Med. Chem. 49, 7160-7168
30. 2 and the ErbB3 receptor, a member of the epidermal growth factor receptor family. Regul. Pept. 87, 73-82
31. Senbonmatsu, T., Saito, T., Landon, E. J., Watanabe, O., Price, E., Roberts, Jr, R. L., Imboden, H., Fitzgerald, T. G., Gaffney, F. A. and Inagami, T. (2003) A novel angiotensin II type 2 receptor signaling pathway: possible role in cardiac hypertrophy. EMBO. J. 22, 6471-6482
32. Fritz, R. D. and Radziwill, G. (2005) The scaffold protein CNK1 interacts with the angiotensin II type 2 receptor. Biochem. Biophys. Res. Commun. 338, 1906-1912
33. 2 and Na+ /H+ exchanger NHE6 in mammalian cells. Peptides 26, 863-873
34. Kang, K. H., Park, S. Y., Rho, S. B. and Lee, J. H. (2008) Tissue inhibitor of metalloproteinases-3 interacts with angiotensin II type 2 receptor and additively inhibits angiogenesis. Cardiovasc. Res. 79, 150-160
35. 2 receptor-interacting protein, ATIP. J. Biol. Chem. 279, 28989-28997
36. 2 receptor by a novel membrane-associated Golgi protein. Arterioscler., Thromb., Vasc., Biol. 25, 57-64
37. Seibold, S., Rudroff, C., Weber, M., Galle, J., Wanner, C. and Marx, M. (2003) Identification of a new tumor suppressor gene located at chromosome 8p21.3-22. FASEB. J. 17, 1180-1182
38. Di, Benedetto, M., Pineau, P., Nouet, S., Berhouet, S., Seitz, I., Louis, S., Dejean, A., Couraud, P. O., Strosberg, A. D., Stoppa-Lyonnet, D. and Nahmias, C. (2006) Mutation analysis of the 8p22 candidate tumor suppressor gene ATIP/MTUS1 in hepatocellular carcinoma. Mol. Cell. Endocrinol. 252, 207-215
39. Frank, B., Bermejo, J. L., Hemminki, K., Sutter, C., Wappenschmidt, B., Meindl, A., Kiechle, M., Bugert, P., Schmutzler, R. K., Bartram, C. R. and Burwinkel, B. (2007) Copy number variant in the candidate tumor suppressor gene MTUS1 and familial breast cancer risk. Carcinogenesis 28, 1442-1445
40. 2 receptor-interacting proteins, ATIP. Gene 380, 127-136
41. Wu, L., Iwai, M., Nakagami, H., Li, Z., Chen, R., Suzuki, J., Akishita, M., de, Gasparo, M. and Horiuchi, M. (2001) Roles of angiotensin II type 2 receptor stimulation associated with selective angiotensin II type 1 receptor blockade with valsartan in the improvement of inflammation-induced vascular injury. Circulation 104, 2716-2721
42. Iwai, M., Chen, R., Li, Z., Shiuchi, T., Suzuki, J., Ide, A., Tsuda, M., Okumura, M., Min, L. J., Mogi, M. and Horiuchi, M. (2005) Deletion of angiotensin II type 2 receptor exaggerated atherosclerosis in apolipoprotein E-null mice. Circulation 112, 1636-1643
43. Fujita, T., Mogi, M., Min, L. J., Iwanami, J., Tsukuda, K., Sakata, A., Okayama, H., Iwai, M., Nahmias, C., Higaki, J. and Horiuchi, M. (2009) Attenuation of cuff-induced neointimal formation by overexpression of angiotensin II type 2 receptor-interacting protein 1. Hypertension 53, 688-693
44. 2 receptor in left ventricular hypertrophy. J. Hypertens. 28 (Suppl. 1), S50-S55
45. Kaschina, E., Grzesiak, A., Li, J., Foryst-Ludwig, A., Timm, M., Rompe, F., Sommerfeld, M., Kemnitz, U. R., Curato, C., Namsolleck, P. et al. (2008) Angiotensin II type 2 receptor stimulation: a novel option of therapeutic interference with the renin-angiotensin system in myocardial infarction? Circulation 118, 2523-2532
46. Nguyen, G., Delarue, F., Burckĺe, C., Bouzhir, L., Giller, T. and Sraer, J. D. (2002) Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J. Clin. Invest 109, 1417-1427
47. 2 receptormediated apoptosis in rat fetal vascular smooth muscle cell. Cardiovasc. Res. 49, 863-871
48. Lehtonen, J. Y., Daviet, L., Nahmias, C., Horiuchi, M. and Dzau, V. J. (1999) Analysis of functional domains of angiotensin II type 2 receptor involved in apoptosis. Mol. Endocrinol. 13, 1051-1060
49. 2-mediated ITIM-independent activation of SHP-1. Proc. Natl. Acad. Sci. U.S.A. 99, 12049-12054
50. 2 receptor-interacting protein and Src homology 2 domain-containing protein-tyrosine phosphatase 1. Mol. Endocrinol. 21, 49-511
51. Min, L. J., Mogi, M., Iwanami, J., Li, J. M., Sakata, A., Fujita, T., Tsukuda, K., Iwai, M. and Horiuchi, M. (2008) Angiotensin II type 2 receptor deletion enhances vascular senescence by methyl methanesulfonate sensitive 2 inhibition. Hypertension 51, 1339-1344
52. Benson, S. C., Pershadsingh, H. A., Ho, C. I., Chittiboyina, A., Desai, P., Pravenec, M., Qi, N., Wang, J., Avery, M. A. and Kurtz, T.W. (2004) Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARγ -modulating activity. Hypertension 43, 993-1002
53. Schupp, M., Janke, J., Clasen, R., Unger, T. and Kintscher, U. (2004) Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-γ activity. Circulation 109, 2054-2057
54. Iwanami, J., Mogi, M., Tsukuda, K., Min, L. J., Sakata, A., Jing, F., Iwai, M. and Horiuchi, M. (2010) Low dose of telmisartan prevents ischemic brain damage with peroxisome proliferator-activated receptor-γ activation in diabetic mice. J. Hypertens. 28, 1730-1737
55. Tsukuda, K., Mogi, M., Iwanami, J., Min, L. J., Sakata, A., Jing, F., Iwai, M. and Horiuchi, M. (2009) Cognitive deficit in amyloid-β-injected mice was improved by pretreatment with a low dose of telmisartan partly because of peroxisome proliferator-activated receptor-γ activation. Hypertension 54, 782-787
56. Washida, K., Ihara, M., Nishio, K., Fujita, Y., Maki, T., Yamada, M., Takahashi, J., Wu, X., Kihara, T., Ito, H. et al. (2010) Nonhypotensive dose of telmisartan attenuates cognitive impairment partially due to peroxisome proliferator-activated receptor-γ activation in mice with chronic cerebral hypoperfusion. Stroke 41, 1798-1806
57. B̈ahr, I. N., Tretter, P., Kr̈uger, J., Stark, R. G., Schimkus, J., Unger, T., Kappert, K., Scholze, J., Parhofer, K. G. and Kintscher, U. (2011) High-dose treatment with telmisartan induces monocytic peroxisome proliferator-activated receptor-γ target genes in patients with the metabolic syndrome. Hypertension 58, 725-732
58. Takeda, K., Ichiki, T., Tokunou, T., Funakoshi, Y., Iino, N., Hirano, K., Kanaide, H. and Takeshita, A. (2000) Peroxisome proliferator-activated receptor γ activators downregulate angiotensin II type 1 receptor in vascular smooth muscle cells. Circulation 102, 1834-1839
59. Sugawara, A., Takeuchi, K., Uruno, A., Ikeda, Y., Arima, S., Kudo, M., Sato, K., Taniyama, Y. and Ito, S. (2001) Transcriptional suppression of type 1 angiotensin II receptor gene expression by peroxisome proliferator-activated receptor-γ in vascular smooth muscle cells. Endocrinology 142, 3125-3134
60. Tham, D. M., Martin-McNulty, B., Wang, Y. X., Wilson, D.W., Vergona, R., Sullivan, M. E., Dole, W. and Rutledge, J. C. (2002) Angiotensin II is associated with activation of NF-κB-mediated genes and downregulation of PPARs. Physiol. Genomics 11, 21-30
61. 12 14-prostaglandin J2 and thiazolidinediones activate the MEK/ERK pathway through phosphatidylinositol 3-kinase in vascular smooth muscle cells. J. Biol. Chem. 276, 48950-48955
62. Zhao, Y., Foryst-Ludwig, A., Bruemmer, D., Culman, J., Bader, M., Unger, T. and Kintscher, U. (2005) Angiotensin II induces peroxisome proliferator-activated receptor γ in PC12W cells via angiotensin type 2 receptor activation. J. Neurochem. 94, 1395-1401
63. Prinster, S. C., Hague, C. and Hall, R. A. (2005) Heterodimerization of G protein-coupled receptors: specificity and functional significance. Pharmacol. Rev. 57, 289-298
64. 1 receptor antagonist. J. Biol. Chem. 276, 39721-39726
65. 1 receptor dimers of monocytes at the onset of atherosclerosis. Cell 119, 343-354
66. Miura, S., Karnik, S. S. and Saku, K. (2005) Constitutively active homo-oligomeric angiotensin II type 2 receptor induces cell signaling independent of receptor conformation and ligand stimulation. J. Biol. Chem. 280, 18237-18244
67. 2 receptor oligomers mediate G-protein dysfunction in an animal model of Alzheimer disease. J. Biol. Chem. 284, 6554-6565
68. 1 receptor dimerization. Cardiovasc. Res. 79, 169-178
69. 1 receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness. Nat. Med. 7, 1003-1009
70. 1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration. Nature 407, 94-98
71. 1R/B2R heterodimer? J. Biol. Chem. 284, 1831-1839
72. 1 and epidermal growth factor receptors. Mol. Pharmacol. 68, 356-364
73. 1 and D3 dopamine receptors in renal proximal tubule cells of SHR. Hypertension 41, 724-729
74. Zeng, C., Liu, Y., Wang, Z., He, D., Huang, L., Yu, P., Zheng, S., Jones, J. E., Asico, L. D., Hopfer, U. et al. (2006) Activation of D3 dopamine receptor decreases angiotensin II type 1 receptor expression in rat renal proximal tubule cells. Circ. Res. 99, 494-500
75. 1 receptor interaction in spontaneously hypertensive rats. Hypertension 42, 787-792
76. Zeng, C., Yang, Z., Wang, Z., Jones, J., Wang, X., Altea, J., Mangrum, A. J., Hopfer, U., Sibley, D. R., Eisner, G. M. et al. (2005) Interaction of angiotensin II type 1 and D5 dopamine receptors in renal proximal tubule cells. Hypertension 45, 804-810
77. Zeng, C., Wang, Z., Asico, L. D., Hopfer, U., Eisner, G. M., Felder, R. A. and Jose, P. A. (2005) Aberrant ETB receptor regulation of AT receptors in immortalized renal proximal tubule cells of spontaneously hypertensive rats. Kidney Int. 68, 623-631
78. 1 receptor in the amygdala. J. Neurophysiol. 83, 2012-2021
79. Bond, R. A. and Ijzerman, A. P. (2006) Recent developments in constitutive receptor activity and inverse agonism, and their potential for GPCR drug discovery. Trends Pharmacol. Sci. 27, 92-96
80. Zou, Y., Akazawa, H., Qin, Y., Sano, M., Takano, H., Minamino, T., Makita, N., Iwanaga, K., Zhu, W., Kudoh, S. et al. (2004) Mechanical stress activates angiotensin II type 1 receptor without the involvement of angiotensin II. Nat. Cell Biol. 6, 499-506
81. Miura, S. and Karnik, S. S. (2002) Constitutive activation of angiotensin II type 1 receptor alters the orientation of transmembrane Helix-2. J. Biol. Chem. 277, 24299-24305